Back to Trades
Sell4
Royalty Pharma plc
RPRX
Total Value
$2.7M
Net $2.7M sold
Sales
$2.7M
4 transactions
Company Information
- Company Name
- Royalty Pharma plc
- Ticker Symbol
- RPRX
- CIK
- 0001802768
Insider Information
- Role
- EVP & CFO
- Location
- NEW YORK, NY
Officer
Filing Details
- Filing Date
- Nov 26, 2025
- Transaction Date
- Nov 24, 2025
- Accession Number
- 0001814876-25-000007
- Form Type
- 4
- Net Trading Amount
- -$2.7M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 24, 2025 | Class A Ordinary Shares | 55,146 | $38.67 | Sale | $2.1M |
| Nov 24, 2025 | Class A Ordinary Shares | 10,686 | $37.96 | Sale | $405.6K |
| Nov 24, 2025 | Class A Ordinary Shares | 3,126 | $38.67 | Sale | $120.9K |
| Nov 24, 2025 | Class A Ordinary Shares | 624 | $37.96 | Sale | $23.7K |
Footnotes
- (F1)All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 8, 2025.
- (F2)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.33 to $38.96 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.32 to $38.31 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.